The American Invents Act could have a big effect on the life sciences industry. Kevin Matha spoke with Robert A Armitage, senior vice president and general counsel at Eli Lilly, about the new legislative package
Tom Ciotti and Kate Murashige of Morrison & Foerster have been involved with the life sciences industry for almost 50 years. Phillip Bausk spoke with them about the changes they have seen in that time
Edward J Farrington of Inspicos considers the role of human intervention when acertaining the limits of patentability in plant breeding
Louise Tottie and Anette Romare of Valea outline important aspects of selection inventions relating to lists and ranges, to consider when drafting patent applications
Agustín Azcatl, Daniel Sánchez and Pedro Herrera of Olivares & Cia explain the impact of rule changes on first medical-use claims
Ha Kung Wong and John Kirkland of Fitzpatrick Cella Harper & Scinto use three scenarios to examine the impact of the Act and the future of paragraph IV litigation
The week in IP - @mdloney's round-up: Rihanna, DC Comics, Lycos, Rockstar Games, Alibaba http://t.co/MgIDUYBk9B http://t.co/ZSw4U4dLrU
Lisbon Union members adopt new Treaty & Regulations @WIPO ($/trial) http://t.co/HBZTxdpBx1 #GI #trademark http://t.co/yP77IuUKdt
Have you used the new, improved search function on our website? Here's what a search for "google" returns http://t.co/4dnpb35mBf
Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego
The voices of IP - from 1990 to 2015
Over the past 25 years, Managing IP has interviewed most of the influential people in IP.
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2015 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International